Shimoyama T - Search Results

1

[Treatment of infections of the current interest. 1) Helicobacter pylori infection].

Shimoyama T, Kashihara W, Okui M, Shintani S, Takada F. Shimoyama T, et al. Nihon Naika Gakkai Zasshi. 1998 Nov 10;87(11):2263-7. Nihon Naika Gakkai Zasshi. 1998. PMID: 9921212 Review. Japanese. No abstract available.

2

[Helicobacter pylori infections in animal models].

Fukuda Y, Yamamoto N, Okui M, Shintani S, Sakagami T, Sawada Y, Tamura K, Shimoyama T. Fukuda Y, et al. Among authors: shimoyama t. Nihon Naika Gakkai Zasshi. 1998 May 10;87(5):819-25. Nihon Naika Gakkai Zasshi. 1998. PMID: 9648431 Review. Japanese. No abstract available.

3

Helicobacter pylori infection affects gastric ulcer healing in Japanese monkeys.

Okui M, Fukuda Y, Yamamoto I, Shintani S, Shimoyama T. Okui M, et al. Among authors: shimoyama t. J Gastroenterol. 1998;33 Suppl 10:26-30. J Gastroenterol. 1998. PMID: 9840013

4

Experimental gastric carcinogenesis related to Helicobacter pylori.

Shimoyama T, Fukuda Y, Sakagami T, Yamamoto N, Kashihara W, Okui M, Tanida N, Tamura K. Shimoyama T, et al. Hepatogastroenterology. 2001 Nov-Dec;48(42):1531-6. Hepatogastroenterology. 2001. PMID: 11813566

5

Chemical structure of lipid A from Helicobacter pylori strain 206-1 lipopolysaccharide.

Suda Y, Ogawa T, Kashihara W, Oikawa M, Shimoyama T, Hayashi T, Tamura T, Kusumoto S. Suda Y, et al. Among authors: shimoyama t. J Biochem. 1997 Jun;121(6):1129-33. doi: 10.1093/oxfordjournals.jbchem.a021705. J Biochem. 1997. PMID: 9354387 Free article.

6

Combination therapy with mucosal protective agent for the eradication of Helicobacter pylori.

Fukuda Y, Yamamoto I, Okui M, Tonokatsu Y, Tamura K, Shimoyama T. Fukuda Y, et al. Among authors: shimoyama t. Eur J Gastroenterol Hepatol. 1995 Aug;7 Suppl 1:S45-7. Eur J Gastroenterol Hepatol. 1995. PMID: 8574735 Clinical Trial.

7

Immunobiological activities of chemically defined lipid A from Helicobacter pylori LPS in comparison with Porphyromonas gingivalis lipid A and Escherichia coli-type synthetic lipid A (compound 506).

Ogawa T, Suda Y, Kashihara W, Hayashi T, Shimoyama T, Kusumoto S, Tamura T. Ogawa T, et al. Among authors: shimoyama t. Vaccine. 1997 Oct;15(15):1598-605. doi: 10.1016/s0264-410x(97)00102-3. Vaccine. 1997. PMID: 9364689

8

Helicobacter pylori infection increases mucosal permeability of the stomach and intestine.

Fukuda Y, Bamba H, Okui M, Tamura K, Tanida N, Satomi M, Shimoyama T, Nishigami T. Fukuda Y, et al. Among authors: shimoyama t. Digestion. 2001;63 Suppl 1:93-6. doi: 10.1159/000051918. Digestion. 2001. PMID: 11173917

9

Chemical structure and biological activity of a lipid A component from Helicobacter pylori strain 206.

Suda Y, Kim YM, Ogawa T, Yasui N, Hasegawa Y, Kashihara W, Shimoyama T, Aoyama K, Nagata K, Tamura T, Kusumoto S. Suda Y, et al. Among authors: shimoyama t. J Endotoxin Res. 2001;7(2):95-104. J Endotoxin Res. 2001. PMID: 11521089

10

Combination therapies with a proton pump inhibitor for Helicobacter pylori-infected gastric ulcer patients.

Fukuda Y, Yamamoto I, Okui M, Tonokatsu Y, Shimoyama T. Fukuda Y, et al. Among authors: shimoyama t. J Clin Gastroenterol. 1995;20 Suppl 2:S132-5. doi: 10.1097/00004836-199506002-00036. J Clin Gastroenterol. 1995. PMID: 7594330 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

798 results

Search Page

Filters